AUSTIN, Texas--(BUSINESS WIRE)--Introgen Therapeutics, Inc. (NASDAQ:INGN) announced today that it will deliver a presentation at the Annual BIO CEO & Investor Conference, the annual investor conference for the biotechnology industry, being held in New York. David G. Nance, Introgen’s Chairman and CEO, is scheduled to present on Wednesday, February 13, 2008, at 11:45 a.m. E.T. Mr. Nance’s presentation will be webcast live and will be available at http://www.introgen.com
